Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-012869

President and CEO sold 14,343 shares at $19.60 ($281,123)

  • President and CEO acquired 14,343 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McCarthy Sean A. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-20 Exercise or conversion : show line 1 in the form +14,343 $0.95 $13,554 16,322 D
2017-03-20 Sale : show line 2 in the form −14,343 $19.60 $281,123 1,979 D
Open-market sales · 14,343 sh · avg $19.60 · $281,123

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-03-20 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −14,343 82,415 D
Loading xslF345X03/doc1.xml…